Misquita Engg. (542801)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 60.69% indicates strong demand for the company's products.
• Latest quarter sales of ₹9 Cr against a market cap of ₹30 Cr implies an attractive price-to-sales ratio of roughly 0.8x on an annualised basis.
• Low absolute market cap of ₹30 Cr leaves room for a large percentage upside if profitability normalises.
• No dividend payout means all capital remains inside the business for reinvestment.

Concerns

• P/E of 314.35 with latest quarter net profit near ₹0 makes the valuation entirely dependent on future recovery.
• Profit growth of -21.05% despite 60.69% sales growth signals severe margin compression or rising costs.
• ROCE of 1.86% is far below any realistic cost of capital, suggesting no economic moat or pricing power.
• Piotroski F-score of 4/9 and PEG of 5.18 point to weak fundamental quality and expensive growth.

AI Analysis

At ₹80, Misquita Engineering is a micro-cap industrial products company with a market cap of just ₹30 crore. The first thing that strikes me is the valuation: 314 times earnings for a business whose latest quarter net profit is essentially zero. That is not investing; that is hope. Revenue growth of 60.69% is eye-catching, and the latest quarter shows ₹9 crore of sales, so there is clearly demand for the product. But a 60% rise in sales alongside a 21% fall in profits tells me this growth is not translating into shareholder earnings. Return on capital employed of just 1.86% is far below any acceptable threshold; a business earning that little on its capital has no moat. The Piotroski score of 4/9 also signals weak financial health. To be fair, the market cap of ₹30 crore against annualised latest-quarter sales of roughly ₹36 crore implies a price-to-sales ratio below 1, so the stock is not expensive on a revenue basis. But without reliable book value, debt figures, or promoter holding data, I cannot complete the Graham-style margin-of-safety analysis. The stock also trades below its 52-week range of ₹88–142, which tells me the market is losing confidence. This looks like a possible turnaround situation, but it is only for a patient speculator. I need to see strong sales eventually flow into net profit. If management cannot improve ROCE and generate real cash earnings, then this growth is worthless to a conservative value investor.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer